No significant differences in allele frequency and genotype distribution of LRP5 rs556442 were found between NAFLD patients and controls, CHD patients and controls, NAFLD + CHD patients and healthy controls, NAFLD patients and NAFLD + CHD patients, or lean NAFLD patients and obese NAFLD patients (Table 2). Here, LRP5 is linked to metabolic dysfunction-associated steatotic liver disease.